Skip to content

Study of Mindfulness Practice Efficacy in Alcoholic Relapse Prevention

Study of Mindfulness Practice Efficacy in Alcoholic Relapse Prevention

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03150550
Acronym
Mindfulness
Enrollment
200
Registered
2017-05-12
Start date
2017-01-21
Completion date
2018-09-30
Last updated
2017-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use Disorder

Keywords

Mindfulness, Alcohol, Alcohol Use Disorder, Relapse, Relapse Prevention, Cognitive-behavioral therapy

Brief summary

Among behavioral cognitive psychotherapies, new Mindfulness interventions allow patient to identify, pay attention and accept external (sensory stimuli) and internal (cognition and emotions) phenomena. This to do with training has yielded promising results in stress management, prevention of depressive relapse, management of craving and an increase in self-efficacy. Few studies (none in France) have attempted to measure the efficacy of this technique on alcohol relapse, in particular by comparing it with a usual management strategy (conventional relapse prevention therapy). The main objective of this study is to compare the efficacy on alcoholic relapse (measured in the first glass consumed), from a Mindfulness therapeutic program to a conventional Relapse Prevention program. Secondary objectives are to demonstrate the efficacy of this program on craving, self-efficacy, and secondary endpoints of relapse (massive alcoholism, number of alcoholisation days).

Detailed description

Each patient will perform 12 psychotherapeutic sessions (Mindfulness or Relapse Prevention) over a period of 6 weeks. Patients will be evaluated by a practitioner different from the practitioner who makes the psychotherapeutic management. Patients will be assessed at inclusion (Initial visit), after the 12 sessions of management (M0), 1 month (M1), 2 month (M2), 3 month (M3), 4 month (M4), 5 month (M5), 6 month (M6), after initial visit as follows Initial Visit * Signature of an informed consent form. * Demographic characteristics (gender, age, family status, professional status, level of education …) * Clinical data (patient status, ongoing pharmacological treatment, withdrawal, previous CBT ...) * Criteria and severity of alcohol dependence (DSM 5) * Evaluation of depressive symptomatology and severity (HAM-D) * Level of pre-intervention alcohol consumption (AUDIT-C) * Binge drinking consumption * Craving before alcohol withdrawal (EVA craving) * Mindfulness Skills (KIMS) * Self-efficacy to remain abstinent (QAE-Alcohol) * Drinking habits (QHPBA) After the 12 sessions (M0) * Data on treatments in progress or change in treatment * Depressive symptomatology and severity (HAM-D) * Level of alcohol consumption in post-intervention (AUDIT-C) * Binge drinking consumption * Craving after alcohol withdrawal (EVA craving) * Mindfulness Skills (KIMS) * Self-efficacy to remain abstinent (QAE-Alcohol) * Distribution of the 1st Daily Alcohol Logbook (TLFB) At 1 month (M1) * Return of the 1st Daily Alcohol Logbook (TLFB) * Data on treatments in progress or change in treatment * Mindfulness Skills (KIMS) * Binge drinking consumption * Self-efficacy to remain abstinent (QAE-Alcohol) * Distribution of the 2nd Daily Alcohol Logbook (TLFB) At 2 month (M2) * Return of the 2nd Daily Alcohol Logbook (TLFB) * Data on treatments in progress or change in treatment * Mindfulness Skills (KIMS) * Binge drinking consumption * Self-efficacy to remain abstinent (QAE-Alcohol) * Distribution of the 3th Daily Alcohol Logbook (TLFB) At 3 month (M3) * Return of the 3th Daily Alcohol Logbook (TLFB) * Data on treatments in progress or change in treatment * Mindfulness Skills (KIMS) * Binge drinking consumption * Self-efficacy to remain abstinent (QAE-Alcohol) * Distribution of the 4th Daily Alcohol Logbook (TLFB) At 4 month (M4) * Return of the 4th Daily Alcohol Logbook (TLFB) * Data on treatments in progress or change in treatment * Mindfulness Skills (KIMS) * Binge drinking consumption * Self-efficacy to remain abstinent (QAE-Alcohol) * Distribution of the 5th Daily Alcohol Logbook (TLFB) At 5 month (M5) * Return of the 5th Daily Alcohol Logbook (TLFB) * Data on treatments in progress or change in treatment * Mindfulness Skills (KIMS) * Binge drinking consumption * Self-efficacy to remain abstinent (QAE-Alcohol) * Distribution of the 6th Daily Alcohol Logbook (TLFB) At 6 month (M6) * Return of the 6th Daily Alcohol Logbook (TLFB) * Data on treatments in progress or change in treatment * Mindfulness Skills (KIMS) * Binge drinking consumption * Self-efficacy to remain abstinent (QAE-Alcohol)

Interventions

Mindfulness interventions are behavioral cognitive psychotherapies which allow patient to identify, pay attention and accept external (sensory stimuli) and internal (cognition and emotions) phenomena.

It's a conventional relapse prevention program which allow to measure the alcoholic relapse in the first glass consumed.

Sponsors

Lundbeck SAS 37-45
CollaboratorUNKNOWN
University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Simple Blind

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Male or female aged 18 to 75 (including landmarks) * Patients in withdrawal for alcohol dependence according to DSM IV criteria (1994); hospital or outpatient withdrawal of more than 10 days and less than 10 weeks.

Exclusion criteria

* Psychiatric comorbidity (dipsomaniac alcoholism, anteriority of one or more hypomanic or manic episodes, psychoses, severe depression, severe suicidal risk) * Other addiction syndrome than tobacco and alcohol * Problems that impede participation in a group, such as severe borderline personality disorder; antisocial personality; tendency to dissociation; phobias of interceptive type (panic attacks and hypochondria ...) * Problems preventing the completion of questionnaires, such as cognitive dysfunctions, dysfunctions of attention and concentration skills, or a language barrier * Severe recurring pathology * Need for individual weekly follow-up

Design outcomes

Primary

MeasureTime frameDescription
Number of alcoholic relapses6 monthProportion of patients with an alcohol consumption of at least one glass of alcohol

Secondary

MeasureTime frameDescription
Delay in heavy drinking relapse6 monthMeasurement : Number of days elapsed between the end of treatment and the first heavy drinking (≥4 glasses of alcohol for women and ≥6 glasses of alcohol for men) compare between the two interventions (classic or mindfulness)
Frequency of consumption6 monthMeasurement : Number of consumption days during 6 month compare between the two interventions (classic or mindfulness)
Daily quantities consumed6 monthMeasurement : Number of standard glasses consumed per day during 6 month compare between the two interventions (classic or mindfulness)
Alcohol relapse time6 monthMeasurement : Number of days elapsed between the end of treatment and the first relapse compare between the two interventions (classic or mindfulness)
Severity of alcohol craving6 monthMeasurement: Assessed daily on a VAS craving (Visual analogue scale) in the daily observation book, compare before and after intervention (classic or mindfulness)
Level of self-efficacy6 monthMeasurement: Assessed daily on a VAS self-efficacy (Visual analogue scale) in the daily observation book, compare before and after intervention (classic or mindfulness)
Degree of mindfulness skills6 monthMeasurement : Score at the KIMS Scale (Kentucky Inventory of Mindfulness Skills) evaluated each month, compare before and after intervention (classic or mindfulness)

Countries

France

Contacts

Primary ContactPatrick LACARIN
placarin@chu-clermontferrand.fr04 73 75 11 95
Backup ContactJulie GENESTE
j_geneste@chu-clermontferrand.fr04 73 75 47 84

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026